Kai Wang

18PUBLICATIONS
7CO-AUTHORS
Predictive and prognostic markersEnvironmental biogeochemistryPreventative health careHaematological tumoursMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 04, 2026
ICAM-1 Hypomethylation Predicts Poor Prognosis in Patients With Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.

|Apr 08, 2026
Exposure to Environmental Pollutants and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study.

Ying Zhang, Han-Xu Zhu, Feng Zhang

|Jan 06, 2026
Silybin for Liver Diseases via Anti-Oxidative Stress: A Comprehensive Review.

Chao Cui, Jingfei Shi, Yu Sun

|Dec 24, 2025
Systematic meta-analysis of the toxicities and side effects of the targeted drug lenvatinib.

Huihui Liu, Kai Wang, Yu Sun

|Nov 19, 2025
Fibroblast growth factor 21 (FGF21) promoter methylation drives the progression of chronic hepatitis B by mediating oxidative stress and inflammatory immunity.

Xue Li, Feng Zhang, Hanxu Zhu

|Oct 09, 2025
TUBB1 promoter methylation is a promising biomarker for predicting HBeAg seroconversion in chronic hepatitis B.

Tong Zhao, Yuna Tang, Yu Sun

Pageof 3

Frequent Collaborators

4 joint publications

Shuai Gao

3 joint publications

Chao Cui

3 joint publications

Jingfei Shi

2 joint publications

Hui-Hui Liu